Franklin Resources
FOMX

Franklin Resources’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Franklin Resources’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,473,026
Closed -$5.89M – 1587
2019
Q2 		$5.89M Sell
2,473,026
-151,419
-6% -$452K ﹤0.01% 993
2019
Q1 		$9.8M Hold
2,624,445
– – 0.01% 884
2018
Q4 		$9.42M Buy
2,624,445
+302,700
+13% +$1.32M 0.01% 878
2018
Q3 		$13.3M Buy
2,321,745
+826,200
+55% +$4.73M 0.01% 877
2018
Q2 		$7.49M Hold
1,495,545
– – ﹤0.01% 976
2018
Q1 		$7.67M Buy
1,495,545
+900
+0.1% +$5.42K ﹤0.01% 967
2017
Q4 		$8.98M Sell
1,494,645
-1,325
-0.1% -$7.97K ﹤0.01% 971
2017
Q3 		$8.3M Sell
1,495,970
-3,400
-0.2% -$17.6K ﹤0.01% 986
2017
Q2 		$6.96M Buy
1,499,370
+500
+0% +$2.23K ﹤0.01% 1031
2017
Q1 		$7.42M Sell
1,498,870
-40,400
-3% -$389K ﹤0.01% 1034
2016
Q4 		$17.1M Hold
1,539,270
– – 0.01% 829
2016
Q3 		$14.3M Buy
1,539,270
+1,300
+0.1% +$10.9K 0.01% 891
2016
Q2 		$9.8M Sell
1,537,970
-1,090
-0.1% -$7.23K 0.01% 974
2016
Q1 		$10M Sell
1,539,060
-136,000
-8% -$877K 0.01% 985
2015
Q4 		$13.6M Sell
1,675,060
-17,140
-1% -$128K 0.01% 938
2015
Q3 		$12.4M Buy
1,692,200
+129,400
+8% +$1.32M 0.01% 966
2015
Q2 		$16M Buy
+1,562,800
New +$17.3M 0.01% 937

Other funds holding FOMX

Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Sofinnova Investments
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Senvest Management
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DLD Asset Management
DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Franklin Resources's FOMX Position: Q3 2019 in Review

Franklin Resources sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2019, closing a stake of 2,473,026 shares — an estimated $5.89M sold.

Franklin Resources first reported a position in FOMX in Q2 2015 and held it in 17 quarters. The position peaked at $17.1M in Q4 2016. 59 funds tracked by Wall St. Rank hold FOMX as of Q3 2019.

  • Franklin Resources reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • Franklin Resources sold 2,473,026 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2019, an estimated $5.89M.
  • Franklin Resources first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 17 quarters.
  • Franklin Resources's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $17.1M in Q4 2016.
  • 59 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2019.

Based on Franklin Resources's 13F filing for Q3 2019, filed 14 Nov 2019.